MBody AI Ltd(MBAI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 29 at 4:00 PM ET (Korea 10/30 05:00)
Full metrics table
| Index | - | P/E | 0.4 | EPS (ttm) | 5.17 | Insider Own | 51.67% | Shs Outstand | 15.3M | Perf Week | 1.95% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 7.4M | Perf Month | -40.96% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | - | Inst Own | 0.08% | Short Float | 0.22% | Perf Quarter | -71.83% |
| Income | 0.00B | P/S | - | EPS this Y | - | Inst Trans | 77.28% | Short Ratio | 0.7 | Perf Half Y | -79.69% |
| Sales | 0.00B | P/B | 0.61 | EPS next 5Y | - | ROA | - | Short Interest | 0.02M | Perf YTD | -81.57% |
| Book/sh | 3.43 | P/C | 145.31 | EPS past 3/5Y | - | ROE | - | 52W High | -92.38% ($27.44) | Perf Year | -79.41% |
| Cash/sh | 0.01 | P/FCF | - | Sales past 3/5Y | - | ROIC | 120.45% | 52W Low | 20.81% ($1.73) | Perf 3Y | -91.35% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 10.48% 10.32% | Perf 5Y | -98.33% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.34 | Perf 10Y | -99.94% |
| Dividend Ex-Date | - | Quick Ratio | 0.05 | EPS Q/Q | 1.58% | Profit Margin | - | RSI (14) | 27.75 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.05 | Sales Q/Q | - | SMA20 | -21.5% ($2.66) | Beta | 0.8 | Target Price | $10 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/08/03 | SMA50 | -55.96% ($4.75) | Rel Volume | 1.08 | Prev Close | $2.05 |
| Employees | - | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -77.34% ($9.22) | Avg Volume(3M) | 0.02M | Price | $2.09 |
| IPO | 2015/3/18 | Option/Short | No/Yes | Trades | 196 | Volume | 24,901 | Change | 2.2% |
🤖 An ultra-small Embodied AI company that integrates the control of robots, sensors, and autonomous mobile units into a single "AI Orchestrator" layer to automate tasks in hospitality, logistics, healthcare, and office settings. This Nasdaq-listed company was reborn in December 2025 through a reverse merger with Check-Cap, an Israeli medical device company that was originally developing a colorectal cancer screening capsule.
Over the past 1 year, on the lower side
92% below its 1-year high.
Traded about as much as usual. That is 108% of its average volume.
MBAI earns moderately but has a weak balance sheet
Tap to view numbers
Within its industry, it looks cheap
For a company earning $100 a year, you would pay $40. Peers typically go for $2,730.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -98.3%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 0.1%.
Tap to view numbers
It ranks #151 of 181 in the industry
Based on market cap of $32M.
FAQ
What kind of company is MBAI?
MBAI belongs to the Technology sector and operates in the Software - Infrastructure industry.
What is the market cap of MBAI?
The market cap of MBAI is approximately $32M, ranking 5,053 within its sector.
What is the P/E ratio of MBAI?
MBAI has a P/E ratio of approximately 0.4x, which can be used to assess its valuation relative to the Technology sector average.
What is the 52-week high and low for MBAI?
MBAI has recorded a 52-week high of $27.44 and a low of $1.73.
